CompletedNCT00900484
SWOG-8819 Collecting, Analyzing, and Storing Tissue Samples From Patients With Non-Hodgkin's Lymphoma
Studying Burkitt lymphoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- SWOG Cancer Research Network
- Principal Investigator
- Lisa Rimsza, MDUniversity of Arizona
- Intervention
- biologic sample preservation procedure(other)
- Enrollment
- 458 enrolled
- Eligibility
- 16 years · All sexes
- Timeline
- 1989 – 2011
Study locations (30)
- Alaska Regional Hospital Cancer Center, Anchorage, Alaska, United States
- Alta Bates Summit Comprehensive Cancer Center, Berkeley, California, United States
- Peninsula Medical Center, Burlingame, California, United States
- North Bay Cancer Center, Fairfield, California, United States
- California Pacific Medical Center - California Campus, San Francisco, California, United States
- Sutter Health - Western Division Cancer Research Group, San Rafael, California, United States
- Sutter Solano Medical Center, Vallejo, California, United States
- Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center, Hartford, Connecticut, United States
- H. Lee Moffitt Cancer Center and Research Institute at University of South Florida, Tampa, Florida, United States
- Piedmont Hospital, Atlanta, Georgia, United States
- Northside Hospital Cancer Center, Atlanta, Georgia, United States
- Saint Joseph's Hospital of Atlanta, Atlanta, Georgia, United States
- CCOP - Atlanta Regional, Atlanta, Georgia, United States
- WellStar Cobb Hospital, Austell, Georgia, United States
- John B. Amos Cancer Center, Columbus, Georgia, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00900484 on ClinicalTrials.govOther trials for Burkitt lymphoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1, PHASE2NCT07069699Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC GeneNational Cancer Institute (NCI)
- RECRUITINGEARLY PHASE1NCT07429461Clinical Study of SYNCAR-100 in the Treatment of Relapsed/Refractory Acute B-Lymphoblastic LeukemiaZhejiang University
- RECRUITINGEARLY PHASE1NCT06793241Donor Derived CD19 CAR-T Cells in the Treatment of R/R B-cell Acute Lymphoblastic LeukemiaZhejiang University
- RECRUITINGPHASE2, PHASE3NCT06764238Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL ProtocolInstitute of Hematology & Blood Diseases Hospital, China
- RECRUITINGNCT06796517Immunotherapy in LymphomaSung-Soo Park
- RECRUITINGPHASE1NCT06060782Thiotepa, Cyclophosphamide, Clarithromycin and CytarabineFifth Affiliated Hospital, Sun Yat-Sen University
- RECRUITINGPHASE2NCT06179524CAR-T-19 Injection in the Treatment of CD19-positive Relapsed/Refractory B-ALLBeijing Yongtai Ruike Biotechnology Company Ltd
- RECRUITINGPHASE1NCT06056752QH103 Cell Injection for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic LeukemiaAnhui Provincial Hospital